Profiel
Gonzalo de Miquel is currently a Member-Supervisory Board at Ventaleon GmbH since 2017.
Previously, he worked as Director-Global Clinical Development at Almirall SA, Independent Director at ALK-Abello A, and Vice President-Clinical Development at AstraZeneca PLC.
He also served as Chief Medical Officer & Executive VP-Development at Vectura Group Ltd.
from 2017 to 2020.
Actieve functies van Gonzalo de Miquel
Bedrijven | Functie | Begin |
---|---|---|
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Director/Board Member | 12-10-2017 |
Eerdere bekende functies van Gonzalo de Miquel
Bedrijven | Functie | Einde |
---|---|---|
VECTURA GROUP | Chief Tech/Sci/R&D Officer | 01-03-2020 |
ALK-ABELLÓ A/S | Director/Board Member | - |
ALMIRALL, S.A. | Corporate Officer/Principal | - |
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
ALMIRALL, S.A. | Health Technology |
ALK-ABELLÓ A/S | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Health Technology |